205 related articles for article (PubMed ID: 30701562)
41. Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes.
Höhlich BJ; Wiesmüller KH; Haas B; Gerner W; Correa R; Hehnen HR; Schlapp T; Pfaff E; Saalmüller A
J Gen Virol; 2003 Dec; 84(Pt 12):3315-3324. PubMed ID: 14645912
[TBL] [Abstract][Full Text] [Related]
42. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats.
Park ME; Lee SY; Kim RH; Ko MK; Lee KN; Kim SM; Kim BK; Lee JS; Kim B; Park JH
Vaccine; 2014 Sep; 32(40):5221-7. PubMed ID: 25066738
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].
Tang H; Liu X; Fang Y; Jiang S; Pan L; Lv J; Zhang Z; Zhou P; Zhang Y; Wang Y
Wei Sheng Wu Xue Bao; 2013 Jun; 53(6):596-607. PubMed ID: 24028062
[TBL] [Abstract][Full Text] [Related]
44. Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus.
Zheng M; Jin N; Zhang H; Jin M; Lu H; Ma M; Li C; Yin G; Wang R; Liu Q
J Virol Methods; 2006 Sep; 136(1-2):230-7. PubMed ID: 16780963
[TBL] [Abstract][Full Text] [Related]
45. Sindbis virus replicase-based DNA vaccine construct encoding FMDV-specific multivalent epitope gene: studies on its immune responses in guinea pigs.
Dar PA; Ganesh K; Nagarajan G; Sarika S; Reddy GR; Suryanarayana VV
Scand J Immunol; 2012 Oct; 76(4):345-53. PubMed ID: 22702835
[TBL] [Abstract][Full Text] [Related]
46. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
47. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
[TBL] [Abstract][Full Text] [Related]
48. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
[TBL] [Abstract][Full Text] [Related]
49. Bi-functional gold nanocages enhance specific immunological responses of foot-and-mouth disease virus-like particles vaccine as a carrier and adjuvant.
Teng Z; Sun S; Luo X; Zhang Z; Seo H; Xu X; Huang J; Dong H; Mu S; Du P; Zhang Z; Guo H
Nanomedicine; 2021 Apr; 33():102358. PubMed ID: 33484882
[TBL] [Abstract][Full Text] [Related]
50. Upconversion nanoparticles modified with aminosilanes as carriers of DNA vaccine for foot-and-mouth disease.
Guo H; Hao R; Qian H; Sun S; Sun D; Yin H; Liu Z; Liu X
Appl Microbiol Biotechnol; 2012 Sep; 95(5):1253-63. PubMed ID: 22476264
[TBL] [Abstract][Full Text] [Related]
51. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
[TBL] [Abstract][Full Text] [Related]
52. Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity.
Rai DK; Segundo FD; Schafer E; Burrage TG; Rodriguez LL; de Los Santos T; Hoeprich PD; Rieder E
Virology; 2016 Aug; 495():136-47. PubMed ID: 27209448
[TBL] [Abstract][Full Text] [Related]
53. Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit.
Hu B; Li C; Lu H; Zhu Z; Du S; Ye M; Tan L; Ren D; Han J; Kan S; Wang J; Jin N
J Virol Methods; 2011 Jan; 171(1):272-9. PubMed ID: 21129406
[TBL] [Abstract][Full Text] [Related]
54. Virus-like particles of recombinant PCV2b carrying FMDV-VP1 epitopes induce both anti-PCV and anti-FMDV antibody responses.
Li X; Meng X; Wang S; Li Z; Yang L; Tu L; Diao W; Yu C; Yu Y; Yan C; Wang L
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10541-10550. PubMed ID: 30338355
[TBL] [Abstract][Full Text] [Related]
55. Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.
Tajdini F; Amini MA; Mokarram AR; Taghizadeh M; Azimi SM
Pharm Dev Technol; 2014 May; 19(3):333-41. PubMed ID: 23590209
[TBL] [Abstract][Full Text] [Related]
56.
An W; Defaus S; Andreu D; Rivera-Gil P
Front Immunol; 2021; 12():684612. PubMed ID: 34220835
[TBL] [Abstract][Full Text] [Related]
57. Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants.
Yang Y; Teng Z; Lu Y; Luo X; Mu S; Ru J; Zhao X; Guo H; Ran X; Wen X; Sun S
Res Vet Sci; 2021 May; 136():89-96. PubMed ID: 33592449
[TBL] [Abstract][Full Text] [Related]
58. A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs.
De Vleeschauwer AR; Zhou X; Lefebvre DJ; Garnier A; Watier F; Pignon C; Lacour SA; Zientara S; Bakkali-Kassimi L; De Clercq K; Klonjkowski B
Vaccine; 2018 Apr; 36(16):2193-2198. PubMed ID: 29544690
[TBL] [Abstract][Full Text] [Related]
59. Biodegradable Imiquimod-Loaded Mesoporous Organosilica as a Nanocarrier and Adjuvant for Enhanced and Prolonged Immunity against Foot-and-Mouth Disease Virus in Mice.
Yin W; Xuan D; Wang H; Zhou M; Deng B; Ma F; Lu Y; Zhang J
ACS Appl Bio Mater; 2022 Jun; 5(6):3095-3106. PubMed ID: 35679606
[TBL] [Abstract][Full Text] [Related]
60. Needleless intradermal vaccination for foot-and-mouth disease induced granuloma-free effective protection in pigs.
Hwang JH; Lee KN; Kim SM; Lee G; Moon Y; Kim B; Lee JS; Park JH
J Vet Sci; 2019 May; 20(3):e29. PubMed ID: 31161747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
